On August 19, 2026, Icon PLC (ICLR) shares rose 3.2% today, closing at $172.49, which is within its 52-week range of $66.57 to $203.91. This recent uptick in sh

On August 17, 2026, Icon PLC (ICLR) shares rose 3.9%, bringing the current price to $169.45. This price is situated within a 52-week range of $66.57 to $203.91,

The portfolio's return was 9.21% (net) for the reporting period. Centene, ICON and Keurig Dr Pepper were the contributors during the quarter. Intercontinental Exchange, Salesforce and ConocoPhillips were the detractors during the quarter.

ICLR's discounted valuation and $23.4B backlog support upside potential, but falling estimates, weaker margins and execution risks argue for patience.

DUBLIN--(BUSINESS WIRE)--ICON Announces Pricing of USD 2.15 Billion Notes.

ICON's 33.2% rally is backed by stronger proposal flow, bookings and backlog, but weaker earnings and margins cloud the recovery.

DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR) (“ICON”), a world-leading clinical research organization, announced today that its wholly-owned subsidiary, ICON Investments Six Designated Activity Company (the “Issuer”), intends to offer one or more series of senior notes (the “Notes”), in a private offering (the “Offering”) with registration rights, subject to market and other conditions. The Notes will be guaranteed on a senior unsecured basis by ICON.

Avidity Partners Management LP lowered its stake in Icon Plc (NASDAQ: ICLR) by 51.7% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 16,000 shares of the medical research company's stock after selling 17,100 shares during the period. Icon makes up about 0.4%

DUBLIN--(BUSINESS WIRE)--ICON Announces Results of Annual General Meeting.

ICON Public Limited Company (ICLR) Q2 2026 Earnings Call Transcript